Stiftingtalstraße 14 | 8010 Graz, Austria

Cycuria has been selected to present at the Startup Spotlight Stage during the upcoming BIO-Europe Spring partnering conference! Our presentation will showcase Cycuria’s pioneering approach to decoupling toxicity from long-lasting efficacy in the treatment of hematological cancers through our first-in-class, protein-based targeted therapy. We will share our progress to date and our vision for the future, highlighting the transformative potential of our innovation.

📅 Event: BIO-Europe Spring

📍 Location: Allianz MiCo, Milan, Italy

🎤 Session: Startup Spotlight, Coral 2 Room

🕒 Date & Time: 18th March, 15:00-17:00 CET

We look forward to connecting with potential partners, investors, and fellow innovators to explore new opportunities for collaboration. Please reach out via the partnering platform to schedule a meeting.

See you at BIO-Europe Spring!

Share:

More Posts

At Cycuria, we are dedicated to developing novel cytokine-based therapies to dramatically improve outcomes for patients living with cancer, offering hope where traditional treatments have fallen short.